SmartInhaler

Connected inhaler sensor maker Adherium has received 510(k) clearance for US over-the-counter sales of its Hailie sensor, formerly known as Smartinhaler.

New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.

Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system.

Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.

New Zealand-based medical device company Nexus6 has received FDA clearance for its smartphone-connected inhaler, SmartTouch, as a class II medical device.